At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MSB Mesabi
Trading 01-12 10:29:25 EST
40.19
+0.45
+1.12%
High40.20Low39.23Vol9.40K
Open39.35D1 Closing39.74Amplitude2.44%
Mkt Cap527.23MTradable Cap526.82MTotal Shares13.12M
T/O372.28KT/O Rate0.07%Tradable Shares13.11M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

New Crypto Exchange BitGW Offers Secure and Compliant Trading: Review
utoday  ·  01-10 08:07
New Crypto Exchange BitGW Offers Secure and Compliant Trading: Review
Mesoblast (ASX:MSB) Valuation Check As Leadership Changes And Debt Refinancing Reset Expectations
Simply Wall St.  ·  01-09
Mesoblast (ASX:MSB) Valuation Check As Leadership Changes And Debt Refinancing Reset Expectations
Malaysian Shares End in Red Bucking Regional Gains; MSB Global's Shares Rally 18%
MT Newswires Live  ·  01-06
Malaysian Shares End in Red Bucking Regional Gains; MSB Global's Shares Rally 18%
MSB Global Unit, Thai Sin Anant Form Auto Parts JV in Thailand; Shares Rally 18%
MT Newswires Live  ·  01-06
MSB Global Unit, Thai Sin Anant Form Auto Parts JV in Thailand; Shares Rally 18%
Press Release: Mesoblast Announces Changes to Board of Directors' Leadership Roles
Dow Jones  ·  01-02
Press Release: Mesoblast Announces Changes to Board of Directors' Leadership Roles
Press Release: Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line
Dow Jones  ·  2025-12-30
Press Release: Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line
Aspire Announces Major Australia, EU and US Regulatory Milestones, Marking a New Chapter in Its Global Expansion
prnewswire  ·  2025-12-16
Aspire Announces Major Australia, EU and US Regulatory Milestones, Marking a New Chapter in Its Global Expansion
Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD
GlobeNewswire  ·  2025-12-12
Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD
Is Mesoblast (ASX:MSB) Using High-Profile Conferences To Recast Its Core Investment Narrative?
Simply Wall St.  ·  2025-12-11
Is Mesoblast (ASX:MSB) Using High-Profile Conferences To Recast Its Core Investment Narrative?
Mesoblast (ASX:MSB) Valuation Check as Investors Eye Piper Sandler Healthcare Conference Update
Simply Wall St.  ·  2025-12-10
Mesoblast (ASX:MSB) Valuation Check as Investors Eye Piper Sandler Healthcare Conference Update
Matrixport Appoints Dominik Oggenfuss as Chief Executive Officer of Matrixport Asset Management AG
prnewswire  ·  2025-12-10
Matrixport Appoints Dominik Oggenfuss as Chief Executive Officer of Matrixport Asset Management AG
Mesoblast Participation at Piper Sandler Conference
GlobeNewswire  ·  2025-12-04
Mesoblast Participation at Piper Sandler Conference
Mesoblast (ASX:MSB) Is Up 17.3% After Lifting Revenue Guidance and Announcing NIH Trial Collaboration Has The Bull Case Changed?
Simply Wall St.  ·  2025-11-29
Mesoblast (ASX:MSB) Is Up 17.3% After Lifting Revenue Guidance and Announcing NIH Trial Collaboration Has The Bull Case Changed?
A Look at Mesoblast (ASX:MSB) Valuation as New Ryoncil Sales Forecast and Pivotal Trial Spark Attention
Simply Wall St.  ·  2025-11-27
A Look at Mesoblast (ASX:MSB) Valuation as New Ryoncil Sales Forecast and Pivotal Trial Spark Attention
How a Seasoned CFO Appointment Could Shape Mesoblast's (ASX:MSB) Commercial Transformation
Simply Wall St.  ·  2025-11-21
How a Seasoned CFO Appointment Could Shape Mesoblast's (ASX:MSB) Commercial Transformation
Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids
GlobeNewswire  ·  2025-11-21
Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids
iFAST vs SGX: Which Growth Stock Could Deliver Better Returns in 2026?
The Smart Investor  ·  2025-11-17
iFAST vs SGX: Which Growth Stock Could Deliver Better Returns in 2026?
Press Release: James M. O'Brien Appointed Chief Financial Officer at Mesoblast
Dow Jones  ·  2025-11-17
Press Release: James M. O'Brien Appointed Chief Financial Officer at Mesoblast
Mesoblast (ASX:MSB) Valuation Spotlight as FDA Reviews Opioid-Reducing Therapy Data
Simply Wall St.  ·  2025-11-17
Mesoblast (ASX:MSB) Valuation Spotlight as FDA Reviews Opioid-Reducing Therapy Data
FDA Review of Opioid-Reduction Data Could Be a Game Changer for Mesoblast (ASX:MSB)
Simply Wall St.  ·  2025-11-12
FDA Review of Opioid-Reduction Data Could Be a Game Changer for Mesoblast (ASX:MSB)

Introduction

Company Name.
Mesabi
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Mesabi Trust, a royalty trust, engages in iron ore mining business in the United States. Mesabi Trust was founded in 1961 and is based in New York, New York.
Issue price:
--